Hellenic Healthcare Sàrl completed the acquisition of 70.38% stake in Diagnostic and Therapeutic Center of Athens Hygeia SA from Marfin Investment Group Holdings S.A..
The transaction is subject to the usual terms and conditions for transactions of such kinds, including confirmatory legal, financial and tax due diligence, signing of a definitive agreement, approval by competition committee and approval of the offer in the General Meeting of Marfin Investment's shareholders. The transaction was also subject to the approval from the Board of Directors of Marfin Investment and the Board of Directors has unanimously considered the offer to be above satisfactory and has decided to grant an exclusivity period to Hellenic Healthcare. On August 25, 2018, the transaction has been approved by Marfin Investment's shareholders. The relevant agreement is expected to be completed by June 30, 2018. Rothschild & Co acted as financial advisor to Marfin Investment Group Holdings S.A.
Hellenic Healthcare Sàrl completed the acquisition of 70.38% stake in Diagnostic and Therapeutic Center of Athens Hygeia SA (ATSE:HYGEIA) from Marfin Investment Group Holdings S.A. (ATSE:MIG) on November 9, 2018.